Target Price | $8.00 |
Price | $1.07 |
Potential |
647.66%
register free of charge
|
Number of Estimates | 1 |
1 Analyst has issued a Aytu BioScience Inc price target 2026.
The average Aytu BioScience Inc target price is $8.00.
This is
647.66%
register free of charge
|
|
A rating was issued by 1 analysts: 1 Analysts recommend Aytu BioScience Inc to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Aytu BioScience Inc stock has an average upside potential 2026 of
647.66%
register free of charge
|
Jun '24 |
2025 Estimates |
|
---|---|---|
Revenue Million $ | 81.00 | 67.10 |
24.58% | 17.16% | |
EBITDA Margin | 6.64% | 20.94% |
303.23% | 215.27% | |
Net Margin | -21.79% | 6.62% |
25.79% | 130.39% |
1 Analyst has issued a sales forecast Aytu BioScience Inc 2025 . The average Aytu BioScience Inc sales estimate is
This results in the following potential growth metrics:
1 Analyst has issued an EBITDA forecast Aytu BioScience Inc 2025 . The average Aytu BioScience Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
1 Analyst has issued a net profit forecast Aytu BioScience Inc 2025 . The average Aytu BioScience Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Jun '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | -2.86 | 0.72 |
44.03% | 125.17% | |
P/E | 1.49 | |
EV/Sales | 0.05 |
1 Analysts have issued a Aytu BioScience Inc forecast for earnings per share. The average Aytu BioScience Inc EPS is
This results in the following potential growth metrics and future valuations:
Aytu BioScience Inc...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.